CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers. - Kwiatkowski N; Liang T; Sha Z; Collier PN; Yang A; Sathappa M; Paul A; Su L; Zheng X; Aversa R; Li K; Mehovic R; et al. (Cell chemical biology, 2025)